William Blair Maintains Outperform On Cepheid Shares
In a research report issued today, William Blair analyst Brian Weinstein maintained an Outperform rating on Cepheid (NASDAQ:CPHD). No price target was provided.
Weinstein said, “We emphasize that we do not see Cepheid as an Ebola play and we continue to have doubts about the near-term development of any Ebola diagnostic from any company in the space considering the time and other resources needed to develop a product, the small market opportunity, and limitations on where the test could logistically be used. Overall, this quarter was all about proof that the business appears to be clicking on all cylinders as seen by the clean beat and raise.”
According to TipRanks.com, which measures analysts’ and bloggers’ success rate based on how their calls perform, analyst Brian Weinstein has a total average return of 23.6% and a 80.0% success rate. Weinstein has a 31.9% average return when recommending CPHD, and is ranked #481 out of 3336 analysts.